The PENUT (Preterm Epo Neuroprotection) trial is a new study being led by University of Washington researchers who are assessing whether erythropoietin (Epo) can provide neurological protection for infants who are born extremely prematurely. This study is seeking a treatment for the approximately 50,000 infants...
Dr. Aaron Kusano, a resident in the University of Washington Department of Radiation Oncology, has research interests that he admits fall a bit outside the conventional realm of radiation oncology. He has examined the burnout amongst academic chairs of radiation oncology departments in the past. He...
UW Today recently profiled the work of Dr. Mike Bailey and his project team on an ultrasound device that would allow doctors to actually move, rather than break up, kidney stones inside the body. The team has entered the clinical trial phase of their work,...
The Institute of Translational Health Sciences (ITHS) hosted 14 researchers from five different Chinese hospitals on Tuesday, January 14, 2014. The delegation, which was organized and led by Dr. Tim Shi of GlobalMD, was interested in learning more about translational research, the ITHS Clinical Research...
The efforts of 11 researchers who are seeking to advance promising translational health research got a recent boost when the Institute of Translational Health Sciences (ITHS) awarded them more than $100,000 in pilot grants and in-kind support. The research supported by ITHS in this current...
If a trauma patient has uncontrolled bleeding, the therapeutic priority is to stop the bleeding as quickly as possible. However, a patient may have hard-to-diagnose, life-threatening condition called trauma-induced coagulopathy (TIC) that can increase blood loss. A team led by Nathan Sniadecki in the UW Department...
The Institute of Translational Health Sciences has reopened its Gene and Cell Therapy Lab. As a biologic manufacturing facility designed to support Phase I/II clinical trials, the lab recently redesigned its operations to address the unique requirements for novel gene and cell therapy products. Located within...
In the world of drug development, researchers may experience many false starts and tests before a compound successfully makes it through clinical trials and enters the market. In fact, approximately 1 in 12 treatments ever make it to patients. What happens to promising molecular compounds...
If you've been the recipient of ITHS resources, please mention us in your publication, press release, or presentation. Just copy and paste our pre-written text into your document. We’ve included the basic guidelines below. Thank you for your cooperation in acknowledging our support of your work. Example...
Kathleen Myers, MD, MPH wants to help support families with a child who is struggling with mental or behavioral health problems, especially families who live far from the offices of a child and adolescent psychiatrist. From her position at Seattle Children’s Hospital, Myers has been involved in...